Association of Visceral Fat Area, Smoking, and Alcohol Consumption with Reflux Esophagitis and Barrett's Esophagus in Japan. [PDF]
PLoS ONE, 2015 Central obesity has been suggested as a risk factor for gastroesophageal reflux disease. The aim of this study was to evaluate the association of visceral fat area and other lifestyle factors with reflux esophagitis or Barrett's esophagus in Japanese ...
Juntaro Matsuzaki +8 more
doaj +2 more sources
Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned [PDF]
Diagnostics, 2023 Gastroesophageal reflux disease (GERD) has the highest prevalence among diseases of the digestive system and is characterized by a significant decrease in patients’ quality of life, comparable to arterial hypertension and coronary heart disease.
Igor V. Maev +4 more
doaj +2 more sources
From Reflux Esophagitis to Esophageal Adenocarcinoma [PDF]
Digestive Diseases, 2016 Reflux esophagitis causes Barrett's metaplasia, an abnormal esophageal mucosa predisposed to adenocarcinoma. Medical therapy for reflux esophagitis focuses on decreasing gastric acid production with proton pump inhibitors. We have reported that reflux esophagitis in a rat model develops from a cytokine-mediated inflammatory injury, not from a caustic ...
R. Souza
openaire +4 more sources
Reflux Esophagitis and Fatigue: Are They Related? [PDF]
J Clin Med, 2021 Gastroesophageal reflux disease (GERD) is a chronic, recurrent disease. Reflux esophagitis can interfere with sleep via acid reflux, which can cause daytime sleepiness or fatigue. However, little is known about the association between reflux esophagitis and fatigue.
Kang SG +8 more
europepmc +7 more sources
Investigation of the mechanism by which miR-223-3p inhibits reflux esophagitis through targeting the NLRP3 inflammasome [PDF]
BMC GastroenterologyBackground Reflux esophagitis is a common gastrointestinal disorder characterized by significant inflammatory responses. The NLRP3 inflammasome plays a crucial role in inflammation, and miR- 223 - 3p has been found to inhibit its expression by targeting ...
Shuying Lin +4 more
doaj +2 more sources
Reflux Complaints, Symptom Score and the Use of Medication in Patients with Reflux Esophagitis: Results of a Long-Term Follow-Up Study [PDF]
Canadian Journal of Gastroenterology, 2001 Reflux esophagitis requires maintenance treatment. A cross-sectional descriptive study was done to assess the use of medication and prevalence of complaints in patients with esophagitis more than 4.5 years after diagnosis.
Ruud JLF Loffeld
doaj +2 more sources
Trends in proton pump inhibitor use, reflux esophagitis, and various upper gastrointestinal symptoms from 2010 to 2019 in Japan [PDF]
PLoS ONE, 2022 The increasing usage of proton pump inhibitors (PPIs) has been reported worldwide, but information on PPI use in East Asia is inadequate. This study aimed to examine the trends in PPI use in Japan, along with the changes in histamine H2 receptor ...
Nobutake Yamamichi +6 more
doaj +3 more sources
The Scientific World Journal, 2012 Background. Gastroesophageal reflux disease (GERD) is a common disease and a major upper gastrointestinal problem. The purpose of the present study is to evaluate the use of noninvasive 2-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) to
Min-Kuei Tsai +8 more
doaj +2 more sources
PLoS ONE, 2022 Purpose Esophageal atresia (EA) is a congenital anomaly of the foregut. Although the survival has improved over the years there is a significant gastrointestinal morbidity affecting physical function and health-related quality of life.
Felipe Donoso +3 more
doaj +2 more sources
Esophageal Candidiasis in an Infant With Reflux Esophagitis
Journal of Pediatric Gastroenterology and Nutrition, 2000 Aliye Uç, Paula E. North, Wesley Burks
openalex +4 more sources